Kleiner Perkins Caufield & Byers

A sheet of paper reading venture capital

Sanofi-backed Expansion nabs $80M for RNA neurodegenerative work

Expansion Therapeutics wants to go up against Dyne, Locanabio in myotonic dystrophy. The Sanofi, Novartis-backed biotech now has $80M for the rivalry.

Kyle LaHucik Sep 29, 2021 7:00am

ArsenalBio joins next-gen cell therapy field with $85M A round

Oct 17, 2019 7:00am

Kleiner, GV drive gene editing startup Trucode to $34M round

Sep 10, 2019 8:30am

Stroke software builder Viz.ai brings in $21M in series A round

Jul 18, 2018 3:30pm

Tmunity dials series A round up to $135M

Apr 19, 2018 9:15am

Armo taps Celgene, GV for $67M to fuel late-phase I-O R&D

Aug 30, 2017 9:09am